Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Hypersensitivity pneumonitis and its correlation with ambient air pollution in urban India

Sheetu Singh, Bridget F. Collins, Mohan Bairwa, Jyotsna M. Joshi, Deepak Talwar, Nishtha Singh, Jai K. Samaria, Daya K. Mangal, Virendra Singh, Ganesh Raghu
European Respiratory Journal 2019 53: 1801563; DOI: 10.1183/13993003.01563-2018
Sheetu Singh
1Dept Chest and Tuberculosis, SMS Medical College, Jaipur, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bridget F. Collins
2Center for Interstitial Lung Diseases (CILD), Dept of Medicine, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohan Bairwa
3Public Health and Epidemiology, IIHMR University, Jaipur, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jyotsna M. Joshi
4Dept of Pulmonary Medicine, Topiwala National Medical College and BYL Nair Hospital, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepak Talwar
5Dept of Pulmonary and Sleep Care Medicine, Metro Multispeciality Hospital, Noida, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nishtha Singh
6Dept of Pulmonary Medicine, Asthma Bhawan, Jaipur, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jai K. Samaria
7Dept of Chest Disease, Banaras Hindu University, Varanasi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daya K. Mangal
3Public Health and Epidemiology, IIHMR University, Jaipur, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virendra Singh
6Dept of Pulmonary Medicine, Asthma Bhawan, Jaipur, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ganesh Raghu
2Center for Interstitial Lung Diseases (CILD), Dept of Medicine, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

A higher proportion of patients diagnosed with hypersensitivity pneumonitis lives in cities with higher levels of air pollutants. Further studies are warranted to investigate the significance of the association of air pollution to possible causality of HP. http://ow.ly/zH3U30mtocl

To the Editor:

Hypersensitivity pneumonitis (HP) is an immune-mediated lung disease (ILD) caused by sensitisation to inhaled organic antigens or low molecular weight chemical compounds. Recently, there has been increased awareness of environmental factors associated with HP [1]. It has been postulated that when genetically susceptible individuals (“first hit”) are exposed to an inciting antigen (“second hit”) they develop HP [2]. The first hit is essential, as not all who are exposed to an inciting antigen develop disease. The second hit or the inciting antigen may be bacterial, protozoal, animal or insect protein, or rarely a chemical compound. Certain viral infections and high pesticide exposures may be risk factors for development of HP, perhaps by making the lung more susceptible to organic antigen exposure (facilitating a second hit) [3, 4].

The role of ambient air pollution as a promoting factor for the development of HP has not been studied. Levels of air pollutants have increased in urban areas over the past decade [5]. Particulate matter <2.5 µm in diameter (PM2.5) can reach the alveoli. Among measures of air pollution, PM2.5 levels have the greatest health impact; higher PM2.5 levels are associated with early mortality [6]. Recently, the role of particulate matter <10 µm in diameter (PM10) has been associated with increased rate of decline of lung functions in patients with idiopathic pulmonary fibrosis (IPF) [7]. However, the role of air pollution in HP has not been studied.

Recent data from the ILD-India registry showed a high proportion of patients with new-onset ILD in India were diagnosed with HP [1]. Since the majority of patients in the ILD-India registry were recruited from urban areas, we hypothesised that air pollution in cities is a contributing factor to development of HP. The aim of this study was to determine whether there is an association between the proportions of HP cases in various Indian cities and ambient air pollution levels measured by PM2.5 using prospective data from patients diagnosed with HP in the ILD-India registry [1].

The ILD-India registry recruited consecutive consenting patients with ILD from 27 centres across 19 cities in India from March 2012 to June 2015. The study was approved by the institutional review board and clinical trial registry of India (CTRI/2013/05/003674). Nearly half of 1084 patients with new-onset ILD living in India had a clinical diagnosis of HP [1]. We analysed data gathered from patients seen at centres that recruited ≥10 patients diagnosed with ILD from cities where PM2.5 levels during the period of study were available (figure 1a and b). Patients residing in urban areas from 19 centres across 11 cities were included. In the ILD-India registry, 842 (78%) out of 1084 patients diagnosed with ILD were residing in cities with PM2.5 levels during the study period available for analysis. Among those patients, 386 (45.8%) out of 842 were diagnosed with HP. The annual mean PM2.5 levels were obtained retrospectively from data provided by the state pollution control boards to the World Health Organization [8]. PM2.5 levels in various cities were either measured directly or derived from PM10 levels. Stata 14.0 (StataCorp LP, College Station, TX, USA) was used for analyses. Spearman's rank correlation test was used to obtain the coefficient of correlation. A scatter diagram with the best fitting line for linear regression (figure 1c) was generated and Lowess smoothing (figure 1d) was created. Multiple logistic regression analysis was performed to determine the association between the percentage of HP cases and PM2.5 level (continuous variable) after adjusting for age, sex, exposure to birds, moulds, desert coolers, air conditioners and smoking.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

a) The 11 cities studied in the immune-mediated lung disease (ILD)-India registry with their percentage of hypersensitivity pneumonitis (HP) cases and particulate matter <2.5 µm in diameter (PM2.5) levels. b) Map of India showing the locations of the 11 cities. Scatter plots showing correlation between percent of HP cases in 11 cities and PM2.5 levels in that area with c) best fitting line for linear regression and d) Lowess smoothing (r=0.64, p=0.03).

Spearman's rank correlation test revealed a strong positive correlation between the percentage of HP cases in the 11 cities and city PM2.5 levels (r=0.64, p=0.03) (figure 1c and d). Multiple logistic regression analysis revealed that each 1 µg·m−3 increase in PM2.5 level is associated with a 0.7% increase in the risk of developing HP rather than any other ILD (adjusted OR 1.007, 95% CI 1.001–1.013; p=0.017). The sample sizes from patients with IPF and connective tissue-associated ILD from the same cities were too small to draw meaningful conclusions from similar analyses (data not shown).

Our findings raise the possibility of an association between HP diagnosis and environmental air pollution levels. It is apparent that air pollution may be a risk factor for patients to manifest HP similar to previous reports regarding viral infections and pesticide exposure [3, 4]. Our results suggest that, although the confidence interval is wide, the odds of developing HP were 7% greater for every 10-µg·m−3 increase in the air pollution (PM2.5 level). This association was adjusted for possible confounders such as birds, air conditioners, air coolers and moulds. It is apparent, therefore, that the risk of a person to manifest HP due to exposure to a known HP inducer, such as birds, is higher if the person has the same exposure and lives in urban areas. We hypothesise that air pollution is a possible contributing factor in the pathogenesis of HP; a potential mechanism is that fine particulate air pollutants lead to airway inflammation and reduced mucociliary clearance with resultant retention of the inciting antigen in the alveoli leading to an immune-mediated response and clinical manifestation of HP. Of note, ambient air pollution levels in India are significantly higher than those in other countries, including countries where many other ILD registries have been undertaken [8]. Since air pollution has been associated with worsening lung function status in patients with IPF [7], and has also been associated with poor outcomes in lung transplant recipients [9–11], the higher incidence of HP in patients enrolled in ILD-India registry greater than that observed in other registries may in part be attributed to differences in ambient air pollution levels. This will require further study both in India and other countries.

We acknowledge that our study is observational and the results are preliminary. Limitations of our findings include the following. 1) Our data are only from patients clinically diagnosed with HP residing in urban areas where PM2.5 levels were available (patients living in rural and remote areas were not included). 2) Nonuniform health coverage in India led to ILD registry sites being concentrated in urban cities. Thus, patients from rural areas were underrepresented, likely leading to referral bias. 3) It is uncertain whether the air monitors used to measure the PM2.5 levels were in close proximity to the patients’ residences or workplaces. 4) Though multiple logistic regression was used to overcome biases due to other exposures, in a proportion of cases, the inciting agent is unknown and thus not accountable in statistical analysis. 5) PM2.5 levels were derived retrospectively from PM10 levels in the majority of cities from public sources, although derivation of PM2.5 levels from PM10 levels is considered to be fairly accurate [12].

Acknowledging these limitations, our observation that the proportion of new-onset ILD cases clinically diagnosed as HP increased with higher levels of air pollution in several Indian cities deserves further attention. We are hopeful that our results will provoke future studies with longitudinal designs, appropriate comparison groups and study participants that are selected from the population at risk to determine the clinical relevance of any potential association between HP and air pollution.

Acknowledgements

We are grateful to the patients of ILD who consented to participate in the ILD India registry and indebted to all the site investigators Sandeep Katiyar (Chest Care Center, Kanpur, India), Parthasarthi Bhattacharya (Institute of Pulmocare and Research, Kolkata, India), Sudhir Chaudhari (GSVM Medical College, Kanpur, India), A.G. Ghoshal (National Allergy, Asthma, Bronchitis Institute, Kolkata, India), Gayathri Joshi (MS Ramaiah Medical College, Bangalore, India), Nirmal K. Jain (Jain Chest Care Center, Jaipur, India), Surya Kant (King George's Medical University, Lucknow, India), Raja Dhar (Fortis Hospital, Kolkata, India), Rajesh Swarnakar (Getwell Hospital and Research Institute, Nagpur, India), C. Ravindran (Calicut Medical College, Kozhikode, India), D.J. Roy (Pulmonary and Sleep Clinic, Kolkata, India), S.K. Sharma (AIIMS, New Delhi, India), K.R. Sarmah (Gauhati Medical College, Guwahati, India), Bhavin Jankharia (Jankharia Imaging, Mumbai, India), Uma Maheshwari (MS Ramaiah Medical College, Bangalore, India), Vivek Nangia (Fortis Hospital, New Delhi, India) and Rajesh Chawla (Indraprastha Apollo Hospital, New Delhi, India).

Footnotes

  • This study is registered at ctri.ni.in with identifier number CTRI/2013/05/003674.

  • Conflict of interest: S. Singh has nothing to disclose.

  • Conflict of interest: B.F. Collins has nothing to disclose.

  • Conflict of interest: M. Bairwa has nothing to disclose.

  • Conflict of interest: G. Joshi has nothing to disclose.

  • Conflict of interest: D. Talwar has nothing to disclose.

  • Conflict of interest: N. Singh has nothing to disclose.

  • Conflict of interest: J.K. Samaria has nothing to disclose.

  • Conflict of interest: D.K. Mangal has nothing to disclose.

  • Conflict of interest: V. Singh has nothing to disclose.

  • Conflict of interest: G. Raghu has nothing to disclose.

  • Support statement: The registry was partially funded by the Indian Chest Society, limited only to restricted, minimal expenses associated with mailing for data acquisition by the National Data Coordinating Center and sharing with Center for Interstitial Lung Diseases. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received August 17, 2018.
  • Accepted October 21, 2018.
  • Copyright ©ERS 2019

References

  1. ↵
    1. Singh S,
    2. Collins BF,
    3. Sharma BB, et al.
    Interstitial lung disease in India. Results of a Prospective Registry. Am J Respir Crit Care Med 2017; 195: 801–813.
    OpenUrl
  2. ↵
    1. Selman M,
    2. Pardo A,
    3. King TE Jr.
    . Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 2012; 186: 314–324.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Dakhama A,
    2. Hegele RG,
    3. Laflamme G, et al.
    Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999; 159: 1316–1322.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Hoppin JA,
    2. Umbach DM,
    3. Kullman GJ, et al.
    Pesticides and other agricultural factors associated with self-reported farmer's lung among farm residents in the Agricultural Health Study. Occup Environ Med 2007; 64: 334–342.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Cohen AJ,
    2. Brauer M,
    3. Burnett R, et al.
    Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet 2017; 389: 1907–1918.
    OpenUrlPubMed
  6. ↵
    1. Lelieveld J,
    2. Evans JS,
    3. Fnais M, et al.
    The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature 2015; 525: 367–371.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Winterbottom CJ,
    2. Shah RJ,
    3. Patterson KC, et al.
    Exposure to ambient particulate matter is associated with accelerated functional decline in idiopathic pulmonary fibrosis. Chest 2018; 153: 1221–1228.
    OpenUrl
  8. ↵
    WHO Global Urban Ambient Air Pollution Database. 2016. www.who.int/phe/health_topics/outdoorair/databases/cities/en/. Date last accessed: December 15, 2017.
  9. ↵
    1. Kaufman JD,
    2. Raghu G
    . Should we be concerned about air quality as a contributor to poor outcomes in lung transplant recipients? Eur Respir J 2017; 49: 1602369.
    OpenUrlAbstract/FREE Full Text
    1. Benmerad M,
    2. Slama R,
    3. Botturi K, et al.
    Chronic effects of air pollution on lung function after lung transplantationin the Systems Prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study. Eur Respir J 2017; 49: 1600206.
    OpenUrl
  10. ↵
    1. Ruttens D,
    2. Verleden SE,
    3. Bijnens EM, et al.
    An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe. Eur Respir J 2017; 49: 1600484.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Delfino RJ,
    2. Becklake MR,
    3. Hanley JA, et al.
    Estimation of unmeasured particulate air pollution data for an epidemiological study of daily respiratory morbidity. Environ Res 1994; 67: 20–38.
    OpenUrlPubMed
PreviousNext
Back to top
View this article with LENS
Vol 53 Issue 2 Table of Contents
European Respiratory Journal: 53 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hypersensitivity pneumonitis and its correlation with ambient air pollution in urban India
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Hypersensitivity pneumonitis and its correlation with ambient air pollution in urban India
Sheetu Singh, Bridget F. Collins, Mohan Bairwa, Jyotsna M. Joshi, Deepak Talwar, Nishtha Singh, Jai K. Samaria, Daya K. Mangal, Virendra Singh, Ganesh Raghu
European Respiratory Journal Feb 2019, 53 (2) 1801563; DOI: 10.1183/13993003.01563-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Hypersensitivity pneumonitis and its correlation with ambient air pollution in urban India
Sheetu Singh, Bridget F. Collins, Mohan Bairwa, Jyotsna M. Joshi, Deepak Talwar, Nishtha Singh, Jai K. Samaria, Daya K. Mangal, Virendra Singh, Ganesh Raghu
European Respiratory Journal Feb 2019, 53 (2) 1801563; DOI: 10.1183/13993003.01563-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Research letters

  • Dysanapsis and mortality in older adults
  • Nasal stimulation with l-menthol ameliorates breathlessness in ILD
  • Lessons from 2 years of use of the Post-COVID-19 Functional Status scale
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society